Page 10 - Pharmaceutical Firms

China to add 56 drugs to price-slashing bulk-buy programme

China added 56 medicines, including some global blockbuster drugs, to its state bidding programme aimed at procuring key treatments at big discounts in return for offering large-volume state contracts

Pharma firms commit 815,000 doses of remdesivir supply in August

Centre steps up efforts to ramp up production of antiviral drug

Pfizer profit before tax down marginally to Rs 173 crore in June quarter

Revenue stood at Rs 514.89 crore against Rs 544.40 crore for the same period a year ago

World Coronavirus Dispatch: Company insiders make $1 bn in rush for vaccine

UK to quarantine those returning from Spain, Aussi cops win halt to Black Lives Matter stir, Africa's Development Bank approves grants and other pandemic-related news across the globe

Sun Pharma's arm Taro Pharma resolves all cases with US Dept of Justice

Sun Pharma said its American arm Taro Pharmaceutical has resolved all cases involving multi-year investigations by US Department of Justice into the country's generic pharmaceutical industry

US to pay Pfizer, BioNTech $1.95 bn for 100 mn Covid-19 vaccine doses

The companies will not receive any money from the government unless their vaccine succeeds in large clinical trials

Cipla, Amgen settle case involving generic cinacalcet hydrochloride tablets

Drug major Cipla said it has reached settlement with Amgen Inc on pending litigation involving generic cinacalcet hydrochloride tablets

Pharma firms face tough Q1 as sales see sharp drop on Q4 channel stocking

Analysts estimate sequential decline of 18-26% during the quarter

Lupin recalls diabetes treatment drug Metformin Hydrochloride in US

Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market

Pharma SMEs will overcome short-term disruptions: CRISIL SME Tracker

Short-term disruptions include high input costs and various operational challenges.

Zydus Cadila gets USFDA nod to market generic antihistamine tablets

The drug will be manufactured at the group's manufacturing facility in Ahmedabad

Sanofi eyes Covid-19 vaccine approval in early 2021; partners Translate Bio

Many drugmakers are racing to come up with a safe and effective vaccine that can be produced at large scale

Piramal Pharma Solutions to acquire G&W Laboratories' drug facility in US

The site has received certifications from the Food and Drug Administration and European Medicines Agency

Needed: A fresh look at the services sector

A post Covid-19 foreign trade policy must be cognisant of the evolving opportunities and challenges in services trade and must prepare domestic policies and capacity accordingly

Covid-19 impact: Exports dip 60% in Apr, iron ore, pharma only bright spots

Apart from exports, imports too, tumbled 58.7% in April, with all major import products seeing a contraction.

Chinese exceptionalism

Trade ties with China are mutually beneficial but the world should seek transparency about that country's institutions

CordenPharma extends Moderna deal to supply lipids to produce Covid vaccine

The expanded agreement will be effective immediately to help meet Moderna's increasing demand over the coming months

Zydus supplies first batch of 30,000 Covid Kavach Elisa tests to ICMR

Robust antibody tests are critical for surveillance and understanding the proportion of the population exposed to SARS Cov-2 infection

Britain's AstraZeneca to make bn Covid-19 vaccine doses if tests succeed

Drugmaker says it had signed the first agreements to supply at least 400 million doses of the vaccine, which it is developing with Oxford University.

Strides Pharma to conduct trials for potential Covid-19 drug Favipiravir

Favipiravir is manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and was approved for use as an anti-flu drug in the country in 2014